Who
Michael F. Roman
Director
Company insider
Files Form 4 as: Director, Abbott Laboratories; Director, Waystar Holding; Chairman of the Board, 3m.
In numbers
- Trades disclosed
- 197
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $24.3M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 8 Nov 2013
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $38K381 at $98.83 | filing |
| 30 Jun 2026filed 1 Jul 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $38K416 at $90.74 | filing |
| 30 Jun 2026filed 1 Jul 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $38K416 at $90.74 | filing |
| 3 Jun 2026filed 25 Sep 2026 | WAY Waystar HoldingIT Services & Consulting | SEC FORM 4 Code A | —10,446 at $0.00 | filing |
| 3 Jun 2026filed 25 Sep 2026 | WAY Waystar HoldingIT Services & Consulting | SEC FORM 4 Code A | —10,446 at $0.00 | filing |
| 3 Jun 2026filed 3 Jun 2026 | WAY Waystar HoldingIT Services & Consulting | SEC FORM 4 Code A | —9,303 at $0.00 | filing |
| 3 Jun 2026filed 3 Jun 2026 | WAY Waystar HoldingIT Services & Consulting | SEC FORM 4 Code A | —9,303 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —2,286 at $0.00 | filing |
| 24 Apr 2026filed 28 Apr 2026 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —2,286 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $38K367 at $102.67 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $38K367 at $102.67 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $38K301 at $125.29 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $38K301 at $125.29 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $38K281 at $133.94 | filing |
| 30 Jun 2025filed 1 Jul 2025 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $37K271 at $136.01 | filing |
| 16 Jun 2025filed 16 Jun 2025 | WAY Waystar HoldingIT Services & Consulting | SEC FORM 4 Code A | —5,134 at $0.00 | filing |
| 25 Apr 2025filed 29 Apr 2025 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —1,635 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | $35K265 at $132.65 | filing |
| 3 Feb 2025filed 18 Feb 2025 | MMM 3mDiversified Industrials | SEC FORM 4 Code F | —8,600 at $0.00 | filing |
| 3 Feb 2025filed 5 Feb 2025 | MMM 3mDiversified Industrials | SEC FORM 4 Code A | —21,026.99 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.